Study of NeuroAid In Enhancing Recovery After Stroke

Inclusion Criteria: * Subject had cerebral infarction confirmed by Computed Tomography (CT scan or Magnetic Resonance Imaging (MRI) imaging * Presents within 1 month after stroke onset * Presents with motor power of from grade 1 - 4/5 in at least one limb * Has a pre-stroke modified Rankin score ≤ 1. * Age between 21 and 80 years old * Female subjects are eligible to participate in the trial if they are of non childbearing potential (hysterectomy or post-menopausal) * Subject or legally acceptable representative is willing and able to provide written informed consent * Subject and carer are willing and able to comply with investigational drug administration schedule. Exclusion Criteria: * Subject has received thrombolysis * Subject has evidence of intra-cerebral hemorrhage on brain CT scan or MRI * Subject has definite indication for full-dose or long-term anticoagulation therapy * Subject has other significant non-ischemic brain lesion which could affect function disability * Subject has co-existing systemic diseases: terminal cancer, renal failure (creatinine \>200 μmol/L, if known), cirrhosis, severe dementia or psychosis * Subject has a history of previous stroke/s * Subject has participated in another clinical trial within the last three months * Subject has aphasia or any other cognitive disabilities which prevent cooperation with study instructions * Subject has dense hemiplegia (grade 0 motor power) * Subject has haemoglobin level of \<10mg/dl on admission * Subject has a history of craniotomy or seizures